Journal of Nanobiotechnology,
Год журнала:
2024,
Номер
22(1)
Опубликована: Апрель 10, 2024
Photothermal
immunotherapy
is
regarded
as
the
ideal
cancer
therapeutic
modality
to
against
malignant
solid
tumors;
however,
its
benefits
are
often
modest
and
require
improvement.
In
this
study,
a
thermoresponsive
nanoparticle
(BTN@LND)
composed
of
photothermal
agent
(PTA)
pyroptosis
inducer
(lonidamine)
were
developed
enhance
applications.
Specifically,
our
"two-step"
donor
engineering
strategy
produced
strong
NIR-II-absorbing
organic
small-molecule
PTA
(BTN)
that
exhibited
high
NIR-II
performance
(ε
Angewandte Chemie International Edition,
Год журнала:
2024,
Номер
63(14)
Опубликована: Фев. 12, 2024
Abstract
The
fabrication
of
a
multimodal
phototheranostic
platform
on
the
basis
single‐component
theranostic
agent
to
afford
both
imaging
and
therapy
simultaneously,
is
attractive
yet
full
challenges.
emergence
aggregation‐induced
emission
luminogens
(AIEgens),
particularly
those
emit
fluorescence
in
second
near‐infrared
window
(NIR‐II),
provides
powerful
tool
for
cancer
treatment
by
virtue
adjustable
pathway
radiative/non‐radiative
energy
consumption,
deeper
penetration
depth
aggregation‐enhanced
performance.
Although
bulky
thiophene
π‐bridges
such
as
ortho
‐alkylated
thiophene,
3,4‐ethoxylene
dioxythiophene
benzo[
c
]thiophene
are
commonly
adopted
construct
NIR‐II
AIEgens,
subtle
differentiation
their
behaviours
has
be
comprehensively
investigated.
In
this
work,
systematical
investigations
discovered
that
AIEgen
BT‐NS
bearing
possesses
acceptable
intensity,
efficient
reactive
oxygen
species
generation,
high
photothermal
conversion
efficiency.
Eventually,
using
nanoparticles,
unprecedented
performance
fluorescence/photoacoustic/photothermal
imaging‐guided
synergistic
photodynamic/photothermal
elimination
tumors
was
demonstrated.
This
study
thus
offers
useful
insights
into
developing
versatile
systems
clinical
trials.
Angewandte Chemie International Edition,
Год журнала:
2024,
Номер
63(26)
Опубликована: Апрель 19, 2024
The
second
near-infrared
(NIR-II,
1000-1700
nm)
light-activated
organic
photothermal
agent
that
synchronously
enables
satisfying
NIR-II
fluorescence
imaging
is
highly
warranted
yet
rather
challenging
on
the
basis
of
overwhelming
nonradiative
decay.
Herein,
such
an
agent,
namely
TPABT-TD,
was
tactfully
designed
and
constructed
via
employing
benzo[c]thiophene
moiety
as
bulky
electron
donor/π-bridge
tailoring
peripheral
molecular
rotors.
Benefitting
from
its
high
donor-acceptor
strength
finely
modulated
intramolecular
motion,
TPABT-TD
simultaneously
exhibits
ultralong
absorption
in
region,
intense
emission
NIR-IIa
(1300-1500
region
nanoaggregates,
conversion
upon
1064
nm
laser
irradiation.
Those
intrinsic
advantages
endow
nanoparticles
with
prominent
fluorescence/photoacoustic/photothermal
trimodal
imaging-guided
therapy
against
orthotopic
4T1
breast
tumor
negligible
adverse
effect.
Advanced Materials,
Год журнала:
2024,
Номер
36(31)
Опубликована: Май 21, 2024
Fluorescence
imaging
(FLI)-guided
phototheranostics
using
emission
from
the
second
near-infrared
(NIR-II)
window
show
significant
potential
for
cancer
diagnosis
and
treatment.
Clinical
imaging-used
polymethine
ionic
indocyanine
green
(ICG)
dye
is
widely
adopted
NIR
fluorescence
imaging-guided
photothermal
therapy
(PTT)
research
due
to
its
exceptional
photophysical
properties.
However,
ICG
has
limitations
such
as
poor
photostability,
low
conversion
efficiency
(PCE),
short-wavelength
peak,
liver-targeting
issues,
which
restrict
wider
use.
In
this
study,
two
derivatives
are
transformed
into
neutral
merocyanines
(mCy)
achieve
much-enhanced
performance
NIR-II
phototheranostics.
Initial
designs
of
dyes
similar
drawbacks
in
terms
photostability
performance.
One
modified
molecules,
mCy890,
shows
significantly
improved
stability,
an
peak
over
1000
nm,
a
high
PCE
51%,
all
considerably
outperform
ICG.
vivo
studies
demonstrate
that
nanoparticles
mCy890
can
effectively
accumulate
at
tumor
sites
guided
by
imaging.
This
provides
valuable
insights
development
enhanced
Abstract
Infectious
diseases
present
significant
challenges
to
global
health,
thereby
extensively
affecting
both
human
society
and
the
economy.
In
recent
years,
functional
probes
have
demonstrated
remarkable
potential
as
crucial
biomedical
media
for
research
treatment
of
infectious
diseases.
Their
applications
in
realm
include
pathogen
detection,
exploration
biological
mechanisms,
development
anti‐infective
drugs.
This
review
provides
a
concise
introduction
severity,
classification,
pathogenesis
Subsequently,
we
examined
distinctiveness
design
strategies
diagnosing
treating
diseases,
shedding
light
on
their
rationale
using
typical
examples.
We
discuss
current
status
associated
with
clinical
implementation
probes.
Furthermore,
explored
prospects
these
diagnosis
aims
offer
novel
insights
into
diagnostic
broaden
disease
treatment.
Journal of the American Chemical Society,
Год журнала:
2025,
Номер
unknown
Опубликована: Янв. 15, 2025
The
two
contradictory
entities
in
nature
often
follow
the
principle
of
unity
opposites,
leading
to
optimal
overall
performance.
Particularly,
aggregation-induced
emission
luminogens
(AIEgens)
with
donor–acceptor
(D–A)
structures
exhibit
tunable
optical
properties
and
versatile
functionalities,
offering
significant
potential
revolutionize
cancer
treatment.
However,
trapped
by
low
molar
absorptivity
(ε)
owing
distorted
configurations,
ceilings
their
photon-harvesting
capability
corresponding
phototheranostic
performance
still
fall
short.
Therefore,
a
research
paradigm
from
twisted
configuration
near-planar
structure
featuring
high
ε
is
urgently
needed
for
AIEgens
development.
Herein,
introducing
strategy
"motion
stillness"
into
highly
planar
A–D–A
skeleton,
we
successfully
developed
near-infrared
(NIR)-II
AIEgen
Y5-2BO-2BTF,
which
boasts
an
impressive
1.06
×
105
M–1
cm–1
photothermal
conversion
efficiency
(PCE)
77.8%.
modification
steric
hindrance
on
benzene
ring
acceptor
unit
aggregation-caused
quenching
counterpart
Y5-2BO,
meta-CF3-substituted
naphthyl,
leads
reversely
staggered
packing
various
intermolecular
noncovalent
conformational
locks
Y5-2BO-2BTF
("stillness").
Furthermore,
−CF3
moiety
acted
as
flexible
motion
ultralow
energy
barrier,
significantly
facilitating
process
loose
aggregates
("motion").
Accordingly,
nanoparticles
enabled
tumor
eradication
pulmonary
metastasis
inhibition
through
NIR-II
fluorescence-photoacoustic-photothermal
imaging-navigated
type
I
photodynamic-photothermal
therapy.
This
work
provides
first
evidence
that
conformation
stacking
arrangement
could
serve
novel
molecular
design
direction
AIEgens,
shedding
new
light
constructing
superior
agents
bioimaging
Advanced Materials,
Год журнала:
2024,
Номер
36(48)
Опубликована: Окт. 13, 2024
Phototherapy,
such
as
photothermal
therapy
(PTT)
and
photodynamic
(PDT)
has
been
a
powerful
strategy
to
combat
bacterial
infection.
However,
the
compact
cell
membranes
of
pathogenic
bacteria,
especially
drug-resistant
significantly
diminish
efficiency
heat
conduction
impede
entrance
reactive
oxygen
species
(ROS)
into
cells,
resulting
in
unsatisfactory
sterilization.
Enlightened
by
membrane
feature
competent
herein
MXene/CaO
Advanced Functional Materials,
Год журнала:
2024,
Номер
unknown
Опубликована: Авг. 29, 2024
Abstract
The
challenge
in
treating
diabetic
foot
infections
caused
by
drug‐resistant
bacteria
is
rapidly
eradicating
and
accelerating
wound
healing.
NIR‐II‐induced
photothermal
therapy
(PTT)
offers
notable
advantages
over
conventional
treatments,
such
as
broad‐spectrum
bactericidal
efficacy,
better
penetration
depth
biological
tissues,
higher
skin
tolerance
thresholds,
making
it
particularly
suitable
for
addressing
infections.
Herein,
found
that
NIR‐II
dye
IR26
exhibited
good
effects
but
poor
stability.
By
modifying
with
methoxy
triphenylamine
groups,
a
novel
D–A–D‐type
small
molecule
agent
(IRC)
developed,
high
stability
conversion
efficiency
(44.3%).
IRC
maximum
absorption
wavelength
of
1166
nm
emission
1238
nm.
However,
PTT
alone
cannot
effectively
promote
Therefore,
nanoplatforms
(Cur‐IRC@PCM)
are
developed
coloading
curcumin,
natural
wound–healing
compound,
into
thermosensitive
liposomes
to
treat
MRSA‐infected
wounds.
Under
980
laser
irradiation,
Cur‐IRC@PCM
provided
controlled
the
precise
release
synergizing
eradicate
accelerate
closure.
intelligent
antibacterial
also
exhibits
excellent
biocompatibility,
rendering
promising
therapeutic
tool
biomedical
fields
combating
bacterial
Advanced Materials,
Год журнала:
2024,
Номер
unknown
Опубликована: Сен. 9, 2024
Abstract
Bacteria
share
a
longstanding
and
complex
relationship
with
humans,
playing
role
in
protecting
gut
health
sustaining
the
ecosystem
to
cause
infectious
diseases
antibiotic
resistance.
Luminogenic
materials
that
aggregation‐induced
emission
(AIE)
characteristics
have
emerged
as
versatile
toolbox
for
bacterial
studies
through
fluorescence
visualization.
Numerous
research
efforts
highlight
superiority
of
AIE
this
field.
Recent
advances
are
categorized
into
four
areas:
understanding
interactions,
antibacterial
strategies,
diverse
applications,
synergistic
applications
bacteria.
Initial
focuses
on
visualizing
unseen
bacteria
progresses
developing
strategies
involving
electrostatic
amphiphilic
luminogens
(AIEgens),
various
enhance
affinity.
progress
includes
using
photodynamic
photothermal
therapies,
toxicity
studies,
combined
therapies.
Diverse
from
environmental
disinfection
disease
treatment,
utilizing
coatings,
sensors,
wound
healing
materials,
etc.,
also
provided.
Finally,
combining
achieve
enhanced
outcomes
explored.
This
review
summarizes
developmental
trend
is
expected
provide
future
directions
advancing
methodologies.
Abstract
The
induction
of
regulated
cell
death
(RCD)
through
photo/ultrasound
sensitization
therapeutic
agents
has
gained
significant
attention
as
a
vital
approach
to
combat
drug
resistance
in
tumors.
Aggregation‐induced
emission
(AIE)
generate
reactive
oxygen
species
activation,
which
can
synergize
with
RCD
inducers
or
directly
induce
RCD,
ultimately
resulting
the
tumor
cells.
presented
comprehensive
review
delves
into
recent
advancements
AIE
designed
trigger
inducers,
encompassing
apoptosis,
necroptosis,
pyroptosis,
immunogenic
death,
autophagy,
ferroptosis,
and
cuproptosis.
Additionally,
intricate
regulatory
mechanisms
activatory‐AIE
therapeutics
influence
distinct
pathways
are
examined.
A
forward‐looking
perspective
on
future
developments
pertinent
challenges
within
this
exciting
realm
is
presented,
anticipating
continued
evolution
activatable
transformative
enhance
therapy.